The Cigna Group reports company news across its global health business, including Cigna Healthcare, Evernorth Health Services, pharmacy benefit services, specialty pharmacy, specialty distribution and care services. Updates commonly cover quarterly results, financial outlook, pharmacy and health-benefit operations, prior authorization initiatives, credit ratings, dividends and investor conference activity.
Company announcements also address governance and board matters, leadership succession planning, enterprise risk management, foundation and community health programs, and changes tied to its health services portfolio. Its business model combines health insurance and benefits with pharmacy claims administration, formulary management, retail pharmacy network administration, home delivery pharmacy and clinical programs for clients and customers.
The Cigna Group (NYSE:CI) has announced it will release its fourth quarter 2024 financial results on Thursday, January 30, 2025. The results will be published before 6:30 a.m. ET, followed by a management conference call at 8:30 a.m. ET.
Participants are advised to dial in by 8:15 a.m. ET. The call will be accessible via domestic (888-566-1889) and international (773-799-3989) numbers, using passcode 01302025. A replay will be available from 12:30 p.m. ET on January 30 until February 13, 2025.
The conference call will also be streamed live on The Cigna Group's Investor Relations website in listen-only mode. The earnings release and financial supplement will be available on the company's investor website before 6:30 a.m. ET on the release date.
Cigna Healthcare announced a new collaboration with Progyny, Inc (Nasdaq: PGNY) to offer expanded fertility and family-building services for more employers. This comprehensive benefit aims to provide coverage from pre-conception to postpartum care, including surrogacy and adoption. The initiative addresses the affordability challenges employers face and acknowledges the growing demand for such services, with 1 in 6 people affected by infertility globally.
The offering is designed to help employers attract and retain top talent, with 61% of millennials valuing these benefits for company loyalty and 70% willing to change jobs for better family-planning benefits. Progyny's Smart Cycle® design allows employers to simplify coverage based on fertility cycles rather than financial thresholds, offering services such as:
- Access to over 650 premier fertility clinics in the U.S.
- 1:1 personalized support from Patient Care Advocates.
- Pre-conception coaching and clinical programming.
- Prescription fertility medication coverage.
- Customized cycle-based coverage for reproductive technologies.
- Egg and sperm freezing and storage.
- Doula services for labor and delivery.
- Holistic well-being and mental health support.
- Guided support and reimbursement for surrogacy and adoption services.
This new benefit will be available to most of Cigna Healthcare's self-funded employer clients in early fall 2025.
The Cigna Group Foundation has announced 22 recipients for its new grant program focused on improving veteran mental health and housing stability. The initiative commits $9 million over three years to support veterans facing homelessness risks.
The program partners with nonprofit organizations implementing evidence-informed services, particularly targeting underserved populations like women and veterans of color. Many organizations will utilize the Housing First model, which has proven successful in reducing housing placement time from 235 to 35 days and improving housing retention rates.
The selected organizations will focus on three key areas: mobilizing rapid re-housing assistance, navigating complex processes for veterans, and increasing pathways to permanent housing. The foundation prioritized grants in regions where The Cigna Group serves customers with high social determinant health risks, including Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee, and Texas.
Additionally, a $250,000 grant was awarded to Habitat for Humanity International to support veteran homeownership through the HUD-VASH initiative.
The Cigna Group Foundation announced its first round of grant recipients for The Health Equity Impact Fund, allocating $9 million to nonprofits over three years to reduce health disparities. The initial $3 million will be distributed among 15 nonprofits in Hartford, CT, and Houston, TX.
In Hartford, seven organizations will focus on increasing access to culturally appropriate care for Black and Hispanic adults, including health screenings and transportation services. In Houston, eight grantees will work on reducing obesity and diabetes prevalence in Hispanic adults through programs like diabetes reversal, nutrition education, and food accessibility initiatives.
The Cigna Group has reaffirmed its capital priorities and financial outlook for full-year 2024 and 2025. The company expects to achieve a consolidated adjusted income from operations of at least $28.40 per share in 2024 and anticipates an adjusted EPS growth of at least 10% in 2025.
Additionally, Cigna confirmed it is not pursuing a combination with Humana Inc. Instead, it remains focused on strategic, financially attractive acquisitions with a high probability of closing.
Cigna continues to drive shareholder value through dividends and share repurchases. Year-to-date, the company has repurchased $6 billion of stock, including $1 billion in Q4. The company plans to use proceeds from the sale of its Medicare businesses, expected to close in Q1 2025, for further share repurchases and has $5.3 billion remaining on its authorization.
Cigna Healthcare and Infirmary Health have established a Medicare Advantage agreement, enabling Cigna's MA customers to access Infirmary Health's network of hospitals, facilities, and doctors in-network. The agreement includes value-based components aimed at improving customer health, reducing costs, and achieving high-quality ratings. Infirmary Health, Alabama's largest nonprofit healthcare provider, serves 11 counties with over 700 doctors and 6,500 staff members, treating more than 1.5 million patients annually across southern Alabama, the Florida panhandle, and southern Mississippi.
The Cigna Group (NYSE: CI) reported strong Q3 2024 results with total revenues increasing 30% to $63.7 billion. Shareholders' net income was $0.7 billion ($2.63 per share), including a $1.0 billion non-cash loss related to VillageMD. Adjusted income from operations reached $2.1 billion ($7.51 per share), up from $2.0 billion ($6.77 per share) in Q3 2023. Total customer relationships grew 12% to 183.5 million, with pharmacy customers increasing 22% to 120.0 million. The company reaffirmed its 2024 outlook for adjusted income from operations of at least $28.40 per share.
The Cigna Group (NYSE: CI) has announced its Board of Directors has declared a quarterly cash dividend of $1.40 per share of common stock. The dividend will be paid on December 19, 2024, to shareholders of record as of the close of business on December 4, 2024.
Cigna Healthcare, part of The Cigna Group (NYSE: CI), is investing $600,000 to address food insecurity among older Americans. The funds will support 54 community-based organizations across 12 states, impacting an estimated 1.4 million people in need. Programs receiving support include food- and nutrition-based initiatives, food pantries, mobile food deliveries, and nutritional meal boxes.
Dr. Jennifer Gutzmore, chief medical officer for Cigna Healthcare's Medicare business, emphasized the importance of addressing food insecurity to improve health outcomes among seniors. The investment aims to support older adults in maintaining balanced nutrition for their well-being. According to Feeding America, almost 7 million seniors are food insecure, with projections suggesting this number could reach 9 million by 2050.
The Cigna Group (NYSE:CI), a global health company, has announced the release of its third quarter 2024 financial results on Thursday, October 31, 2024. The results will be released no later than 6:30 a.m. Eastern Time (ET), followed by a conference call at 8:30 a.m. ET to review the results.
Participants are advised to dial in by 8:15 a.m. ET. The call-in numbers are: (888) 566-1889 (Domestic) and (773) 799-3989 (International), with the passcode 10312024. A replay will be available from 12:30 p.m. ET on October 31 until 11:59 p.m. ET on November 14, 2024.
The conference call will also be available as a live internet webcast on The Cigna Group's Investor Relations website. The company's news release and financial supplement will be accessible on the same website no later than 6:30 a.m. ET on October 31.